- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05728190
Effect of Aromatherapy on Pain, Anxiety and Sleep Quality in Burn Patients
Effect of Inhalation Aromatherapy on Pain, Anxiety, and Sleep Quality in Burn Patients
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
After 5 patients were included in the sample size of the study, intervention and control groups, power analysis was performed using the G*Power Software (3.1.9.2) program. With a margin of error of 5%, an effect size of 0.15, and a power of 95%, the sample group size was calculated as 54 patients. Considering that data loss might be 10% on average in the study, it was decided to recruit 60 patients. Participants were randomized according to patient rooms. There are a total of 11 rooms and 16 beds in the burn unit, 5 double and 6 single. 11 rooms are numbered sequentially according to their location in the corridor.
In the intervention group, seven drops of lavender essential oil were dripped onto a 5x5 gauze pad in the morning and evening, for 20 minutes, 10 cm away from the nose, and sniffed.
In the placebo control group, seven drops of saline/sterile water were dripped onto a 5x5 gauze pad in the morning and evening, and they were put to sniff for 20 minutes, 10 cm away from the nose. Green food coloring was added (one drop of food coloring to 5 ml of sterile/saline water) to make sterile/saline water similar to lavender oil. Data were collected using Individual Data Collection Form, Spielberg State Anxiety Scale, Visual Analog Scale, Richard Campbell Sleep Scale before and after five days of morning and evening aromatherapy application.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ankara
-
Yenimahalle, Ankara, Turkey, 06050
- Ankara Medipol University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Between the ages of 18-65,
- 2nd and/or 3rd degree burns but not in emergency/resuscitative phase,
- Total body burn area is 5-30%,
- No acute-chronic respiratory system disease (asthma, COPD, etc.),
- No problem in sense of smell,
- No communication problem,
- Not participating in another study at the same time,
- Patients who volunteered to participate in the study.
Exclusion Criteria:
- Those who are allergic to lavender essential oil,
- Having a history of head trauma or convulsions,
- Having respiratory tract (inhalation) burn,
- Having alcohol or narcotic substance addiction,
- Having a history of pregnancy, epilepsy, high blood pressure and migraine,
- Patients undergoing intubation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Lavender essential oil
In the intervention group, five days, seven drops of lavender essential oil were dripped onto a 5x5 gauze pad in the morning and evening, for 20 minutes, 10 cm away from the nose, and sniffed.
|
Five days seven drops of lavender essential oil were dripped onto a 5x5 gauze pad in the morning and evening, for 20 minutes, 10 cm away from the nose, and sniffed.
|
|
Placebo Comparator: Steril/Salin water
Five days seven drops of saline/sterile water were dripped onto a 5x5 gauze pad in the morning and evening, and they were put to sniff for 20 minutes, 10 cm away from the nose.
|
Five days seven drops of saline/sterile water were dripped onto a 5x5 gauze pad in the morning and evening, and they were put to sniff for 20 minutes, 10 cm away from the nose.
Green food coloring was added (one drop of food coloring to 5 ml of sterile/saline water) to make sterile/saline water similar to lavender oil.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Scale
Time Frame: 5 days
|
Grading is made with a 10 cm long horizontal or vertical ruler on the scale and "0" means no pain and "10" means the most severe pain. The patient marks the intensity of pain he feels on the ruler. If the marked value is between 1-4, it indicates mild pain, between 5-6 indicates moderate pain, and between 7-10 indicates severe pain. In the application, the patient was asked to mark the intensity of pain he felt on the ruler and the value was measured and recorded. |
5 days
|
|
Spielberg State Anxiety Scale
Time Frame: 5 days
|
The scale has a four-point Likert structure consisting of 20 items and a total score of 20-80 is obtained. A score of 20 or less indicates that the individual does not have anxiety, a score between 21-39 indicates mild anxiety, a score between 40-59 indicates moderate, and a score between 60-80 indicates a high level of anxiety. |
5 days
|
|
Richard Campbell Sleep Scale
Time Frame: 5 days
|
There are 6 items in the scale.
There are 5 items in the assessment.
Each item is evaluated on the scale between 0 and 100.
If the score is between "0-25", it indicates very bad sleep, and between "76-100" indicates very good sleep.
|
5 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1929/2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aromatherapy
-
Mersin UniversityNot yet recruiting
-
Mansoura UniversityNot yet recruiting
-
Federal University of ParaíbaActive, not recruiting
-
Hong Kong Metropolitan UniversityCompletedAromatherapy | Spasticity as Sequela of StrokeHong Kong
-
Eastern Mediterranean UniversityRecruiting
-
Stanford UniversityRecruitingAromatherapy | Cancer Distress | Cancer Coping | Hematopoetic Stem Cell TransplantUnited States
-
Mardin Artuklu UniversityCompletedMusic Therapy | AromatherapyTurkey
-
TC Erciyes UniversityRecruiting
-
TC Erciyes UniversityCompletedCholecystectomy | AromatherapyTurkey
Clinical Trials on Lavender essential oil
-
Wake Forest University Health SciencesCompletedAnxiety | Anxiety Preoperative
-
Al-Zaytoonah University of JordanCompletedDepressive Symptoms | Preoperative Anxiety | Psychological Stress | Orthopedic Surgery PatientsJordan
-
October University for Modern Sciences and ArtsNot yet recruitingLocal Anesthesia | Dental AnxietyEgypt
-
Federal University of Minas GeraisRecruitingQuality of Life | Infertility | Stress | Anxiety | Spirituality | Complementary Therapies | IVF | Aromatherapy | Depression DisorderBrazil
-
San Gallicano Dermatological Institute IRCCSCompletedMelanoma | Preoperative Anxiety | Non-Melanoma Skin Cancer | pT1aItaly
-
University of Oran 1Not yet recruitingMultiple Sclerosis (MS) | Urinary Urgency | Lower Urinary Tract Symptoms (LUTS) | Neurogenic Bladder Disorder | Urinary Incontinence (UI)Algeria
-
The University of Texas Health Science Center,...HCA Houston Healthcare Southeast HospitalCompletedPostoperative Nausea and Vomiting (PONV)United States
-
Istanbul Aydın UniversityCyprus Aydin UniversityCompletedCardiology | AngiographyTurkey (Türkiye)
-
Huan DingUnknownMild Cognitive ImpairmentChina
-
Mike O'Callaghan Military HospitalAmerican Academy of Family PhysiciansCompletedColposcopyUnited States